February 9, 2023Pharmabiz
Spexis, SGI execute clinical trial partnership to fund up to half of the projected phase 3 clinical development costs of ColiFin
Spexis AG, a clinical─stage biopharmaceutical company focused on rare diseases and oncology, announce... See more »